Ires Ghielen

Table 1. Study characteristics. (continued) Study Medical condition Comorbidity Primary outcome N intervention Intervention N control Control Outcomes in analysis Risk of bias (0-7)* Ghielen et al. (2016) [40] PD Anxiety symptoms GSES 19 ACT+PT 19 TAU (PT) BAI BDI 0-0-1-0-0-0-1 (2) Okai et al. (2013) [41] PD Impulse control disorder(s) NPI 28 CBT 17 WL GHQ ?-0-1-1-1-0-0 (3) Troeung et al. (2014) [42] PD Anxiety and/or depressive symptoms DASS 11 CBT 7 WL DASS-A DASS-D DASS-S 0-0-1-0-0-0-0 (1) Meta-analysis 2 Ehde et al. (2015) [43] MS Fatigue, pain, or depressive symptoms PHQ 75 Self- management 88 PE PHQ 0-0-1-0-0-0-1 (2) Mohr et al. (2001) [44] MS Major depressive disorder HRSD & BDI 20 CBT 22 Supportive expression BDI HRSD 1-?-1-?-0-0-? (5) Mohr et al. (2005) [45] MS Moderate depressive symptoms HRSD & BDI-II 62 CBT 65 Supportive expression BDI-II HRSD 1-?-1-0-0-0-0 (3) Moss-Morris et al. (2013) [46] MS Psychological distress GHQ 48 CBT 46 SL GHQ 0-0-1-0-0-?-0 (2) Nordin et al. (2012) [47] MS Anxiety and/or depressive symptoms HADS 11 ACT 10 Relaxation BDI HADS-A HADS-D 0-?-1-1-0-0-0 (3) Oreja-Guevera et al. (2015) [48] MS Unknown HADS 21 MBSR 20 PE HADS-A Not assessable Carletto et al. (2017) [49] MS Depressive symptoms 43 BAM 45 PE BDI-II BAI PSS 0-0-1-0-0-0-0 (1) *Risk of bias is derived after assigning a zero (low risk of bias (0)) or one (unclear (?) or high risk of bias (1)) to each one of the following quality criteria: allocation sequence, allocation concealment, blinding of participants and personnel, blinding of assessors, incomplete outcome data, selective reporting, and other sources of bias, and a sum score.